(CBK) Commerzbank - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000CBK1001

Loans, Accounts, Cards, Trade Finance, Asset Management

Dividends

Dividend Yield 1.92%
Yield on Cost 5y 12.95%
Yield CAGR 5y 15.02%
Payout Consistency 45.1%
Payout Ratio 28.6%
Risk via 10d forecast
Volatility 35.2%
Value at Risk 5%th 54.1%
Relative Tail Risk -6.63%
Reward TTM
Sharpe Ratio 2.33
Alpha 128.91
CAGR/Max DD 2.35
Character TTM
Hurst Exponent 0.509
Beta 0.213
Beta Downside 0.469
Drawdowns 3y
Max DD 25.68%
Mean DD 7.94%
Median DD 6.84%

Description: CBK Commerzbank December 04, 2025

Commerzbank AG (XETRA: CBK) is a German-headquartered universal bank that serves private-individuals, small-business owners, corporates, financial-service firms and institutional investors across Europe, the Americas and Asia. Its operations are split into two segments – Private & Small-Business Customers and Corporate Clients – delivering a full suite of retail banking products (savings, checking, credit/debit cards, loans, pension and payment solutions) and corporate services (real-estate financing, M&A advisory, trade finance, securities trading, wealth and asset management).

Key recent metrics indicate the bank is navigating a challenging European banking environment: the CET1 capital ratio stood at roughly 13.5 % at year-end 2023, while the cost-to-income ratio improved to about 65 % after a multi-year efficiency program. Net interest income benefited from the ECB’s rate hikes in 2023-24, lifting the net interest margin by ~15 bps, and loan growth remained modest at ~2 % YoY. A sector-wide driver is the ongoing digital transformation, with Commerzbank reporting a 12 % YoY increase in online transaction volume, which is critical for sustaining fee income as traditional margins tighten.

If you want to dig deeper into how these drivers translate into valuation upside or downside for CBK, a quick look at ValueRay’s analytical dashboards can provide a data-rich perspective.

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (2.64b TTM) > 0 and > 6% of Revenue (6% = 1.31b TTM)
FCFTA -0.04 (>2.0%) and ΔFCFTA -7.03pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -1555 % (prev 816.5%; Δ -2372 pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA -0.03 (>3.0%) and CFO -20.32b <= Net Income 2.64b (YES >=105%, WARN >=100%)
Net Debt (-24.24b) to EBITDA (2.86b) ratio: -8.48 <= 3.0 (WARN <= 3.5)
Current Ratio 0.21 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (1.13b) change vs 12m ago -4.83% (target <= -2.0% for YES)
Gross Margin 60.29% (prev 48.17%; Δ 12.12pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 3.76% (prev 4.41%; Δ -0.65pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 0.25 (EBITDA TTM 2.86b / Interest Expense TTM 11.44b) >= 6 (WARN >= 3)

Altman Z'' -3.57

(A) -0.57 = (Total Current Assets 89.93b - Total Current Liabilities 428.75b) / Total Assets 592.95b
(B) 0.03 = Retained Earnings (Balance) 19.39b / Total Assets 592.95b
(C) 0.00 = EBIT TTM 2.89b / Avg Total Assets 579.14b
(D) 0.03 = Book Value of Equity 19.39b / Total Liabilities 557.18b
Total Rating: -3.57 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 49.97

1. Piotroski 5.0pt
2. FCF Yield data missing
3. FCF Margin -98.51%
4. Debt/Equity 1.60
5. Debt/Ebitda -8.48
6. ROIC - WACC (= -2.77)%
7. RoE 7.67%
8. Rev. Trend 44.06%
9. EPS Trend 62.78%

What is the price of CBK shares?

As of December 04, 2025, the stock is trading at EUR 33.84 with a total of 2,248,692 shares traded.
Over the past week, the price has changed by -1.77%, over one month by +5.45%, over three months by +5.92% and over the past year by +137.97%.

Is CBK a buy, sell or hold?

Commerzbank has no consensus analysts rating.

What are the forecasts/targets for the CBK price?

Issuer Target Up/Down from current
Wallstreet Target Price 33 -2.4%
Analysts Target Price - -
ValueRay Target Price 53.9 59.2%

CBK Fundamental Data Overview November 25, 2025

Market Cap USD = 41.88b (35.90b EUR * 1.1666 EUR.USD)
Market Cap EUR = 35.90b (35.90b EUR * 1.0 EUR.EUR)
P/E Trailing = 15.3816
P/E Forward = 11.5607
P/S = 3.1713
P/B = 1.0462
P/EG = 1.2841
Beta = 0.636
Revenue TTM = 21.79b EUR
EBIT TTM = 2.89b EUR
EBITDA TTM = 2.86b EUR
Long Term Debt = 53.33b EUR (from longTermDebt, last fiscal year)
Short Term Debt = unknown (none)
Debt = 54.89b EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -24.24b EUR (from netDebt column, last fiscal year)
Enterprise Value = 21.52b EUR (35.90b + Debt 54.89b - CCE 69.27b)
Interest Coverage Ratio = 0.25 (Ebit TTM 2.89b / Interest Expense TTM 11.44b)
FCF Yield = -99.74% (FCF TTM -21.46b / Enterprise Value 21.52b)
FCF Margin = -98.51% (FCF TTM -21.46b / Revenue TTM 21.79b)
Net Margin = 12.11% (Net Income TTM 2.64b / Revenue TTM 21.79b)
Gross Margin = 60.29% ((Revenue TTM 21.79b - Cost of Revenue TTM 8.65b) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 55.18%)
Tobins Q-Ratio = 0.04 (Enterprise Value 21.52b / Total Assets 592.95b)
Interest Expense / Debt = 5.07% (Interest Expense 2.79b / Debt 54.89b)
Taxrate = 36.42% (374.0m / 1.03b)
NOPAT = 1.84b (EBIT 2.89b * (1 - 36.42%))
Current Ratio = 0.21 (Total Current Assets 89.93b / Total Current Liabilities 428.75b)
Debt / Equity = 1.60 (Debt 54.89b / totalStockholderEquity, last quarter 34.31b)
Debt / EBITDA = -8.48 (Net Debt -24.24b / EBITDA 2.86b)
Debt / FCF = 1.13 (negative FCF - burning cash) (Net Debt -24.24b / FCF TTM -21.46b)
Total Stockholder Equity = 34.40b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.45% (Net Income 2.64b / Total Assets 592.95b)
RoE = 7.67% (Net Income TTM 2.64b / Total Stockholder Equity 34.40b)
RoCE = 3.29% (EBIT 2.89b / Capital Employed (Equity 34.40b + L.T.Debt 53.33b))
RoIC = 1.87% (NOPAT 1.84b / Invested Capital 97.98b)
WACC = 4.64% (E(35.90b)/V(90.79b) * Re(6.80%) + D(54.89b)/V(90.79b) * Rd(5.07%) * (1-Tc(0.36)))
Discount Rate = 6.80% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -4.65%
Fair Price DCF = unknown (Cash Flow -21.46b)
EPS Correlation: 62.78 | EPS CAGR: 11.70% | SUE: -0.35 | # QB: 0
Revenue Correlation: 44.06 | Revenue CAGR: -8.16% | SUE: -0.11 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.77 | Chg30d=-0.044 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=3.01 | Chg30d=+0.052 | Revisions Net=+0 | Growth EPS=+21.5% | Growth Revenue=+7.9%

Additional Sources for CBK Stock

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle